Patents by Inventor Kosuke Funato

Kosuke Funato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THIENOPYRIMIDINES AND USES THEREOF
    Publication number: 20200255447
    Abstract: Described herein are thienopyrimidine compounds of Formula (I), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the thienopyrimidine compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., brain tumors such as DIPGs) in a subject. The invention further provides an embryonic stem cell-based tumor cell model, which can be used for drug screening and disease target identification.
    Type: Application
    Filed: January 6, 2020
    Publication date: August 13, 2020
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Viviane Tabar, Kosuke Funato
  • Thienopyrimidines and uses thereof
    Patent number: 10526341
    Abstract: Described herein are thienopyrimidine compounds of Formula (I), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the thienopyrimidine compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., brain tumors such as DIPGs) in a subject. The invention further provides an embryonic stem cell-based tumor cell model, which can be used for drug screening and disease target identification.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: January 7, 2020
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Viviane Tabar, Kosuke Funato
  • THIENOPYRIMIDINES AND USES THEREOF
    Publication number: 20170355711
    Abstract: Described herein are thienopyrimidine compounds of Formula (I), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the thienopyrimidine compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., brain tumors such as DIPGs) in a subject. The invention further provides an embryonic stem cell-based tumor cell model, which can be used for drug screening and disease target identification.
    Type: Application
    Filed: November 19, 2015
    Publication date: December 14, 2017
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Viviane Tabar, Kosuke Funato